DI CARLO, Francesco

DI CARLO, Francesco  

Mostra records
Risultati 1 - 20 di 109 (tempo di esecuzione: 0.032 secondi).
Titolo Data di pubblicazione Autore(i) File
[Correlation of the biochemical and histochemical determination of hormone receptors in carcinoma of the breast with the age of the patient, stage and histologic type of the neoplasm] 1987 CAMPOBASSO O ;CONCINA S ;COZZANI C ;RIBOTTA M ;DI CARLO F ;CONTI G ;RACCA S
[Distribution of estrogen receptors and progesterone receptors in the human uterus and influence of anesthetic drugs] 1982 RUSSO A ;MONDO F ;FRANCALANCI S ;DI CARLO F ;CONTI G ;RACCA S ;REBOANI C
[The pharmacologic profile of flutamide] 1985 RACCA S ;DI CARLO F
A combined histological, immunocytochemical and biochemical approach in the evaluation of estrogen receptors in breast carcinomas. 1986 PIETRIBIASI F ;GUGLIOTTA P ;RACCA S ;DI CARLO F ;BUSSOLATI G
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. 2012 De Francia S; Massano D; Piccione FM; Pirro E; Racca S; Di Carlo F; Piga A.
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. 2011 Pirro E; De Francia S; De Martino F; Fava C; Ulisciani S; Cambrin GR; Racca S; Saglio G; Di Carlo F
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients 2006 DE FRANCIA S; PIRRO E; ZAPPIA F; DE MARTINO F; SPRIO AE; DAFFARA F; TERZOLO M; BERRUTI A; DI CARLO F; GHEZZO F
A prospective study on adjuvant mitotane 2008 F. Daffara; B. Zaggia; A. Ardito; S. De Francia; G. Reimondo; M. Papotti; M. Volante; F. Di Carlo; A. Angeli; A. Berruti; M. Terzolo.
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 2008 F. Daffara; A. Ardito; S. De Francia; G. Reimondo; M. Papotti; M. Volante; F. Di Carlo; A. Angeli; A. Berruti; M. Terzolo
Androgeni ed antiandrogeni 2010 Di Carlo F; Racca S
Animals models in oral cancer research 2006 B. MOGNETTI; F. DI CARLO; G. BERTA
Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomas 2005 BERTA G N; MOGNETTI B; SPADARO M; TRIONE E; AMICI A; FORNI G; DI CARLO F; CAVALLO F
Antineoplastic effects of SU5416, a novel vascular endothelial growth factor pathway inhibitor, in an oral cancer model 2003 G. BERTA; GIAI PRON R; GHEZZO F; MOGNETTI B; CORVETTI G; LIMONCIELLO V; PIRRO E; TRIONE E; DI CARLO F
Biological and molecular effects of high doses of anabolic steroids 2009 Piccione F; Abbadessa G; Cangemi L; De Francia S; Esculapio P; Penna C; Tullio ; Portaleone P; Pagliaro P; Di Carlo F; Racca S
Calcyclin gene expression modulation by medroxyprogesterone acetate 1997 GHEZZO F; BERTA G.N; BECCARO M; A. D'AVOLIO; RACCA S; CONTI G; DI CARLO F
Calcyclin, b-actin and H3-histone expression is modulated by sex steroids in hormone dependent human mammary cells (CG5) 1996 GHEZZO F; G. BERTA; D'AVOLIO A; RACCA S; CONTI G; DI CARLO F
Carcinoma della cavita' orale: approccio molecolare 1995 G. BERTA; GHEZZO F; D'AVOLIO A; VERCELLINO V; DI CARLO F
Changes in the binding of oestradiol to uterine oestrogen receptors induced by some progesterone and 19-nor-testosterone derivatives. 1983 DI CARLO F ;GALLO E ;CONTI G ;RACCA S
Chemioterapia antineoplastica 2010 Francesco Di Carlo; Giovanni N Berta; Barbara Mognetti; Silvia Racca; Andrea Elio Sprio; Alessandro Barberis
Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of resveratrol complexed with 2-hydroxypropyl-beta-cyclodextrin 2010 Berta GN; Salamone P; Sprio AE; Di Scipio F; Marinos LM; Sapino S; Carlotti ME; Cavalli R; Di Carlo F.